Immunocore To Tap Into HTA Advice To Ensure IMCgp100 Success

British immunotherapy specialist Immunocore plans to make full use of the scientific advice European HTAs are offering to help it progress its lead product IMCgp100 through the European Medicines Agency's Adaptive Pathways pilot program.